Allscripts Healthcare Solutions Now Covered by Raymond James
The firm set an "outperform" rating and a $19.00 price target on the stock. Raymond James' target price would suggest a potential upside of 14.67% from the stock's previous close.
Crain's Chicago Busines
Glen Tullman voluntarily left Allscripts Healthcare Solutions Corp. His 2012 departure as CEO was mischaracterized in an April 7 story.
Citrus Valley Health Partners among first to attest on transition of...
CVHP informed Allscripts that it had transmitted the requisite minimum 10 percent of discharge documentation between disparate electronic health record acute and ambulatory systems.
Activist Investors are Betting on Allscripts Healthcare Solutions Inc.
Activist investors Ricky Sandler of Eminence Capital and Clifton S. Robbins of Blue Harbour Group increased their stakes in Allscripts Healthcare MDRX ) during the fourth quarter of 2013, controlling 4.8% and 4.5%, respectively, of the healthcare technology company at the end of the year.
Neil Versel's Healthcare IT Blog
Another PHR venture (yawn) brings in some big names
I normally shy away from stories about the crowded and, to this point, spectacularly unsuccessful field of untethered personal health records, but one got my attention this week because of the names it's just attracted.